In a pan-cancer (lung cancer, cervical cancer, prostate cancer, pancreatic cancer, colon cancer, kidney cancer, large cell and Hodgkin’s lymphoma, etc.)biomarker research published recently, NOTCH4 may serve as a potential predictive biomarker for ICI treatment (20). This evidence concerns the gene NOTCH4 and cancer.